DRD2 and schizophrenia: For example, the first generation antipsychotic DRD2 antagonist Haloperidol, was also linked to schizophrenia by the off-target GRIN2A, which encodes a subunit of the glutamatergic NMDA receptor involved in synaptic plasticity and learning (Fig. 1).